Rybelsus (semaglutide) has Food and Drug Administration (FDA) approval to manage blood sugar levels in adults with type 2 diabetes. Interested in learning more about it? You’re not alone—many people ...

The approval of medicines called “glucagon-like peptide (GLP-1) agonists” has led to major changes in how type 2 diabetes is managed. These medicines work in a different way than other medicines used ...

Rybelsus is an oral prescription medication used to help manage blood sugar levels in adults with type 2 diabetes. It’s prescribed along with healthy eating and exercise. Rybelsus has a boxed warning ...

People can’t stop talking about semaglutide (Ozempic, Wegovy), the buzzy diabetes and weight loss drug. Ozempic and Wegovy are injectable medications: Users prick themselves with a preloaded syringe ...

John Morton, M.D., M.P.H. Obesity / Health Care Policy Dr. John Morton is the system lead for surgical quality and bariatric services in the Yale New Haven Health System of six hospitals. He is also ...

There are two diabetes medications that are also used for weight loss – Rybelsus and Ozempic. They both contain the same drug called Semaglutide, Rybelsus is an oral medication whereas Ozempic is an ...

What Is Rybelsus, and Why Does It Matter? Rybelsus (semaglutide) is a once-daily pill used to help lower blood sugar in adults with type 2 diabetes (T2D). It belongs to a group of medicines called GLP ...

Down with Rybelsus! No, this isn’t a line from "1984," but rather the new message from Novo Nordisk for its first Rybelsus ad of 2022. One of the biggest issues facing new medicines like Rybelsus, ...

Rybelsus is a Food and Drug Administration (FDA)-approved medication for treating type 2 diabetes. Like Ozempic and Wegovy, it contains the active ingredient semaglutide. This is a type of GLP-1 ...

Rybelsus ® reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial 1.

Novo Nordisk’s diabetes pill Rybelsus, an oral semaglutide, reduced the risk of major heart-related events by 14% in adults with Type 2 diabetes and cardiovascular disease or chronic kidney disease, ...

Rybelsus commonly causes digestive side effects such as nausea, diarrhea, and abdominal pain. Rybelsus carries a boxed warning regarding the risk of thyroid cancer. Other serious side effects of this ...